Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 3, 2010, Pages 338-347

  Wilson, Ira B ^a   Barton Laws, Michael ^a,b   Safren, Steven A ^c   Lee, Yoojin ^a   Lu, Minyi ^a   Coady, William ^a   Skolnik, Paul R ^d   Rogers, William H ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Communication; Electronic monitoring; HIV infections drug therapy; Patient compliance; Physician patient relations,randomized controlled trial

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOCTOR PATIENT RELATION; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE OF HEALTH PERSONNEL; CROSS-OVER STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS;

EID: 77649216964     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c7a245     Document Type: Article

References (55)

1. Palella FJJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338: 853-860.
2. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279: 450-454.
3. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet. 1999;353: 863-868. (Pubitemid 29126872)
4. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ. 1997;315: 1194-1199.
5. Marins JR, Jamal LF, Chen SY, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17:1675-1682.
6. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366:378-384.
7. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
8. Hogg R, Yip B, O'Shaughnessy M, et al. Non-adherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women. Presented at: The XIII International AIDS Conference, Durban, South Africa, July 9-14, 2000.
9. Arnsten JH, Grant RW, Demas PA, et al. Adherence with antiretroviral therapy in HIV-infected drug users. J Gen Intern Med. 1999;14:7.
10. Kleeberger CA, Phair JP, Strathdee SA, et al. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82-92.
11. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
12. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28:124-131.
13. Gallego O, de MC, Perez-Elias MJ, et al. Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS. 2001;15:1701-1706.
14. Wensing AM, van de V, Angarano G, et al. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis. 2005;192:958-966.
15. Pillay D, Green H, Matthias R. et al. Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. J Infect Dis. 2005;192:967-973.
16. World Health Organization. Adherence to Long-Term Therapies. Geneva, Switzerland: World Health Organization; 2003.
17. Simoni JM, Pearson CR, Pantalone DW, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic eview of Randomized Controlled Trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23-S35.
18. Bangsberg DR, Hecht FM, Clague H, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26:435-442.
19. Roth HP, Caron HS. Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen. Clin Pharmacol Ther. 1978; 23:361-370.
20. Caron HS, Roth HP. Patients' cooperation with a medical regimen. Difficulties in identifying the noncooperator. JAMA. 1968;203:922-926.
21. Wagner JH, Justice AC, Chesney M, et al. Patient-and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clin Epidemiol. 2001;54(Suppl 1):S91-S98.
22. Gross R, Bilker WB, Friedman HM, et al. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS. 2002;16:1835-1837.
23. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12:255-266.
24. Rogers WH, Wilson IB, Bungay KM, et al. Assessing the performance of a new depression screener for primary care (PC-SAD). J Clin Epidemiol. 2002;55:164-175.
25. Rogers WH, Adler DA, Bungay KM, et al. Depression screening instruments made good severity measures in a cross-sectional analysis. J Clin Epidemiol. 2005;58:370-377.
26. Ware JJ, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-233.
27. Lu M, Safren SA, Skolnik PR, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008; 12: 86-94.
28. Laws MB, Lu M, Coady W, et al. Impact of an intervention on physician-patient dialogue related to antiretroviral (ARV) adherence. Presented at: 3rd International Conference on HIV Treatment Adherence; March 17-18, 2008; Jersey City, NJ.
29. Laws MB, Lu M, Bradshaw Y, et al. Physician communication styles and their association with antiretroviral adherence. Presented at: XVII International AIDS Conference; August 3-8, 2008; Mexico City, Mexico. #THPE0141.
30. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
31. Tugenberg T, Ware NC, Wyatt M. Paradoxical effects of clinician emphasis on adherence to combination antiretroviral therapy for HIV/ AIDS. AIDS Patient Care STDS. 2006;20:269-274.
32. Barfod TS, Hecht FM, Rubow C, et al. Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory. BMC Health Serv Res. 2006;6:154.
33. Malta M, Petersen ML, Clair S, et al. Adherence to antiretrovial therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. Cad Saude Publica. 2005;21:1424-1432.
34. Gerbert B, Bronstone A, Clanon K, et al. Combination antiretroviral therapy: health care providers confront emerging dilemmas. AIDS Care. 2000;12:409-421.
35. Golin CE, Smith SR, Reif S. Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in North Carolina. J Gen Intern Med. 2004;19:16-27.
36. Harman JJ, Amico KR, Johnson BT. Standard of care: promoting antiretroviral adherence in clinical care. AIDS Care. 2005;17:237-251.
37. Simoni JM, Amico KR, Pearson CR, et al. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10:515-521.
38. Rathbun RC, Farmer KC, Stephens JR, et al. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005;27:199-209.
39. Goujard C, Bernard N, Sohier N, et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;34:191-194.
40. Roter DL, Hall JA. Doctors Talking With Patients. Patients Talking With Doctors. Westport, Connecticut: Auburn House; 1992.
41. Gordon GH, Rost K. Evaluating a faculty development course on medical interviewing. In: Lipkin M Jr, Putnam SM, Lazare A, eds. The Medical Interview: Clinical Care, Education, and Research. New York, NY: Springer-Varlag; 1995:436-447.
42. Thompson TL, Parrott R. Interpersonal communication and health. In: Knapp ML, Daly JA, eds. Handbood of Interpersonal Communication. 3rd ed. Thousand Oaks, CA: SAGE Publications; 2002:680-725.
43. Roter DL, Cole KA, Kern DE, et al. An evaluation of residency training in interviewing skills and the psychosocial domain of medical practice. J Gen Intern Med. 1990;5:347-354.
44. Levinson W, Roter D. The effects of two continuing medical education programs on communication skills of practicing primary care physicians. J Gen Intern Med. 1993;8:318-324.
45. van Dulmen AM, van Weert JC. Effects of gynaecological education on interpersonal communication skills. BJOG. 2001;108:485-491.
46. van Dulmen AM, Holl RA. Effects of continuing paediatric education in interpersonal communication skills. Eur J Pediatr. 2000;159:489-495.
47. Moral RR, Alamo MM, Jurado MA, et al. Effectiveness of a learner-centred training programme for primary care physicians in using a patient-centred consultation style. Fam Pract. 2001;18:60-63.
48. Sliwa JA, Makoul G, Betts H. Rehabilitation-specific communication skills training: improving the physician-patient relationship. Am J Phys Med Rehabil. 2002;81:126-132.
49. Hulsman RL, Ros WJ, Winnubst JA, et al. The effectiveness of a computer-assisted instruction programme on communication skills of medical specialists in oncology. Med Educ. 2002;36:125-134.
50. Roter DL, Hall JA, Kern DE, et al. Improving physicians' interviewing skills and reducing patients' emotional distress. A randomized clinical trial. Arch Intern Med. 1995;155:1877-1884.
51. Wilson IB, Landon BE, Ding L, et al. A national study of the relationship of care site HIV specialization to early adoption of highly active antiretroviral therapy. Med Care. 2005;43:12-20.
52. Wilson IB, Landon BE, Hirschhorn LR, et al. Quality of HIV care provided by nurse practitioners, physician assistants, and physicians. Ann Intern Med. 2005;143:729-736.
53. Stiles WB, Putnam SM. Coding categories for investigating medical interviews: a metaclassification. In: Lipkin M Jr, Putnam SM, Lazare A, eds. The Medical Interview: Clinical Care, Education, and Research. New York, NY: Springer-Verlag; 1995:489-494.
54. Rimal RN. Analyzing the physician-patient interaction: an overview of six methods and future research directions. Health Commun. 2001;13:89-99.
55. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487-497.